Related references
Note: Only part of the references are listed.Cutaneous leishmaniasis: progress towards a vaccine
Pascal Launois et al.
EXPERT REVIEW OF VACCINES (2008)
FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine
Clarisa B. Palatnik-de-Sousa et al.
EXPERT REVIEW OF VACCINES (2008)
Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice
Salvador Iborra et al.
MICROBES AND INFECTION (2008)
Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies
Nicola Kimblin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies
Nathan C. Peters et al.
SCIENCE (2008)
Immunochemotherapy of persistent post-kata-azar dermal leishmaniasis: a novel approach to treatment
Ahmed Mudawi Musa et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
First generation leishmaniasis vaccines: A review of field efficacy trials
Sassan Noazin et al.
VACCINE (2008)
Vaccines for leishmaniasis in the fore coming 25 years
Clarisal B. Palatnik-de-Sousa
VACCINE (2008)
Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani
Emma McFarlane et al.
INFECTION AND IMMUNITY (2008)
Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies
Paul A. Bates
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2007)
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Patricia A. Darrah et al.
NATURE MEDICINE (2007)
Synthetic glycovaccine protects against the bite of Leishmania-infected sand flies
Matthew E. Rogers et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2/monocyte chemoattractant protein-1 expression and macrophage recruitment
CR Teixeira et al.
JOURNAL OF IMMUNOLOGY (2005)
Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia
ID Vélez et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2005)
Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection
KS Tabbara et al.
INFECTION AND IMMUNITY (2005)
Second-generation vaccines against leishmaniasis
RN Coler et al.
TRENDS IN PARASITOLOGY (2005)
Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response
JE Uzonna et al.
JOURNAL OF IMMUNOLOGY (2004)
Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis
RX Armijos et al.
VACCINE (2004)
The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?
CD Gregory et al.
IMMUNOLOGY (2004)
Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG
ME Rogers et al.
NATURE (2004)
Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites
C Zaph et al.
NATURE MEDICINE (2004)
The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development
P Scott et al.
IMMUNOLOGICAL REVIEWS (2004)
Persistence without pathology in phosphoglycan-deficient Leishmania major
GF Späth et al.
SCIENCE (2003)
Immunotherapy of American cutaneous leishmaniasis in Venezuela during the period 1990-99
J Convit et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2003)
Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG
M Mahmoodi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis
RN Coler et al.
INFECTION AND IMMUNITY (2002)
Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection
EG Rhee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation
LM Stuart et al.
JOURNAL OF IMMUNOLOGY (2002)
Immune elimination of Leishmania major in mice:: Implications for immune memory, vaccination, and reactivation disease
JE Uzonna et al.
JOURNAL OF IMMUNOLOGY (2001)
The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure
Y Belkaid et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge
S Méndez et al.
JOURNAL OF IMMUNOLOGY (2001)
Leishmaniasis: Current status of vaccine development
E Handman
CLINICAL MICROBIOLOGY REVIEWS (2001)
Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis:: a randomised, double-blind, BCG-controlled trial in Sudan
EAG Khalil et al.
LANCET (2000)
Corpse clearance defines the meaning of cell death
J Savill et al.
NATURE (2000)
An immunomodulatory function for neutrophils during the induction of a CD4(+) Th2 response in BALB/c mice infected with Leishmania major
F Tacchini-Cottier et al.
JOURNAL OF IMMUNOLOGY (2000)